Feeding America Intervention Trial for Health--Diabetes Mellitus (FAITH-DM)
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Studietype
Registrering (Faktiske)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Oakland, California, Forente stater, 94614
- Alameda County Community Food Bank
-
San Francisco, California, Forente stater, 94143
- University of California San Francisco
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48207
- Gleaners Community Food Bank of Southeastern Michigan
-
-
Texas
-
Houston, Texas, Forente stater, 77029
- Houston Food Bank
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Food pantry client at one of three participating food banks: Alameda County Community Food Bank (Oakland, CA), Gleaners Community Food Bank of Southeastern Michigan (Detroit, MI), Houston Food Bank, (Houston, TX)
- Type II diabetes mellitus with HbA1c ≥ 7.5% using food bank point-of-care testing
- Reliable mode of contact (either phone or address)
- English or Spanish verbal fluency
- 18 years of age or older
- Intent to remain in the study area for at least the next 12 months
- Willingness to participate in intervention
Exclusion Criteria:
- Type 1 diabetes
- Pregnant or less than 6 weeks post-partum
- Cognitively impaired: dementia, mental illness, or active substance abuse severe enough to interfere with administration of the survey or participation in the intervention
- Household member already enrolled in the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Immediate Intervention
Participants randomized to the Intervention Arm will immediately begin a four-component intervention.
|
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Referral to a local primary care provider, if none currently exists.
Coordination of care with primary care provider.
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations.
The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.
|
|
Aktiv komparator: Waitlist Control
Participants randomized to the Waitlist Control arm will receive no intervention for six months, after which time they will begin a modified, four-component intervention.
|
Point-of-care testing of HbA1c levels at the food pantry at approximately 3 month intervals
Referral to a local primary care provider, if none currently exists.
Coordination of care with primary care provider.
Food (perishable and non-perishable) appropriate for diabetes self-management available for pick-up at the food pantry twice monthly.
Education materials drawn from evidence-based practice and adapted from existing diabetes education curricula to be flexible to individual, community, and site variations.
The Immediate Intervention Arm receives more robust diabetes self-management education (with group education visits) than the Waitlist Control Arm.
|
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline HbA1c at 6 Months
Tidsramme: 6 months
|
Point-of-care HbA1c testing with the PTS Diagnostics A1CNow®+ System
|
6 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline Dietary Intake
Tidsramme: 6 months and 12 months
|
Brief fruit & vegetable dietary screener
|
6 months and 12 months
|
|
Change from Baseline Health Care Utilization
Tidsramme: 6 months and 12 months
|
Communication with primary care provider requesting dates of service, service levels, and diagnosis codes
|
6 months and 12 months
|
|
Change from Baseline Diabetes Distress
Tidsramme: 6 months and 12 months
|
Self-reported distress as assessed by the 2-item emotional burden sub-score of the Diabetes Distress Scale
|
6 months and 12 months
|
|
Change from Baseline Hypoglycemic events
Tidsramme: 6 months and 12 months
|
Self-reported hypoglycemic events over the previous 4 weeks, both any events and number of events, and self-reported severe hypoglycemic episodes, both any events and number of events
|
6 months and 12 months
|
|
Change from Baseline Depressive symptoms
Tidsramme: 6 months and 12 months
|
PHQ-8 (a subset of PHQ-9 scores without assessment of suicidality)
|
6 months and 12 months
|
|
Change from Baseline Medication Adherence
Tidsramme: 6 months and 12 months
|
Morisky Medication Adherence Scale (4 items)
|
6 months and 12 months
|
|
Food vs medicine trade-offs
Tidsramme: 6 months and 12 months
|
Three self-reported questions
|
6 months and 12 months
|
|
Change from Baseline Food security status
Tidsramme: 6 months and 12 months
|
6-item version of the USDA's Core Food Security Survey Module
|
6 months and 12 months
|
|
Change from Baseline Food stability
Tidsramme: 6 months and 12 months
|
Two items assessing adequacy of food resources to last the entire month
|
6 months and 12 months
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from Baseline Diabetes Self-Efficacy
Tidsramme: 6 months and 12 months
|
8-item scale of diabetes-specific self-efficacy
|
6 months and 12 months
|
|
Change from Baseline Diabetes Self-Care
Tidsramme: 6 months and 12 months
|
Self-reported assessment of 5 self-care behaviors: medications, exercise, diet, blood sugar monitoring, and foot care
|
6 months and 12 months
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Samarbeidspartnere
Samarbeidspartnere
Etterforskere
Etterforskere
- Hovedetterforsker: Hilary K Seligman, MD MAS, University of California, San Francisco
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Seligman HK, Levi R, Ridberg R, Smith M, Hills N, Waxman E. Impact of Enhanced Food Pantry Services on Food Security among Adults with Diabetes Using a Crossover Study Design. Curr Dev Nutr. 2022 Feb 10;6(4):nzac021. doi: 10.1093/cdn/nzac021. eCollection 2022 Apr.
- Smith M, Rosenmoss S, Seligman HK. Point-of-Care Hemoglobin A1C Testing System in Community Settings: Challenges, Opportunities, and Measurement Characteristics. Prog Community Health Partnersh. 2020;14(3):327-335. doi: 10.1353/cpr.2020.0038.
- Seligman HK, Smith M, Rosenmoss S, Marshall MB, Waxman E. Comprehensive Diabetes Self-Management Support From Food Banks: A Randomized Controlled Trial. Am J Public Health. 2018 Sep;108(9):1227-1234. doi: 10.2105/AJPH.2018.304528. Epub 2018 Jul 19.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Faktiske)
Primær fullføring
Studiet fullført (Faktiske)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- A125548
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .